Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165953 | SCV000216710 | pathogenic | Hereditary cancer-predisposing syndrome | 2014-10-14 | criteria provided, single submitter | clinical testing | The c.131_134dupGCGT pathogenic mutation, located in coding exon 2 of the PTEN gene, results from a duplication of GCGT at position 131, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |